Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMA: Adalimumab + MTX in Early RA
NCT00420927Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Dec 2006
- Primary completion
- Jul 2010
- Modality
- Monoclonal Antibodies
- Countries
- 21
01
Overview
A Phase 4 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Abbott Laboratories. Started Dec 2006; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00420927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00420927.